Furou Pharmaceutical Technology (Huzhou) Co., Ltd.

The time course of blood drug concentration after a single oral dose of the test preparation Perindopril Indapamide Tablets (Specifications: Perindopril tert-butylamine 4 mg, Indapamide 1.25 mg, licensee: Fuo Pharmaceutical Technology (Huzhou) Co., Ltd.) was observed in healthy subjects in the fasting and postprandial states, and the corresponding pharmacokinetic parameters were estimated. Perindopril Indapamide Tablets (trade name: Bipro®, specifications: Perindopril tert-butylamine 4 mg, Indapamide 1.25 mg, licensee: Servier (Tianjin) Pharmaceutical Co., Ltd.) was used as the reference preparation to conduct a formal human bioequivalence trial to provide a reference basis for the registration and clinical application of the drug.

The relative bioavailability and bioequivalence of Aguratimod tablets provided by Fuou Pharmaceutical Technology (Huzhou) Co., Ltd. were evaluated in humans using the Aguratimod tablets provided by Hainan Xiansheng Pharmaceutical Co., Ltd. as the reference preparation.

The fluticasone propionate suspension for nebulized inhalation provided by Fuo Pharmaceutical Technology (Huzhou) Co., Ltd. was used as the test preparation, and the fluticasone propionate suspension for nebulized inhalation certified by Eddingpharm B.V. was used as the reference preparation to evaluate the relative bioavailability and bioequivalence in humans.